Dr. El Jurdi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
909 Fulton St SE
Minneapolis, MN 55455Phone+1 612-672-7422
Education & Training
Tufts Medical CenterResidency, Internal Medicine, 2012 - 2015
American University of Beirut Faculty of MedicineClass of 2011
Certifications & Licensure
MN State Medical License 2017 - 2025
OH State Medical License 2015 - 2018
MA State Medical License 2012 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies Start of enrollment: 2023 May 11
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 6 citationsSarcopenia Predicts Inferior Progression-Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation.Nuttavut Sumransub, Qing Cao, Mark Juckett, Brian Betts, Shernan Holtan
Transplantation and Cellular Therapy. 2023-04-01 - 19 citationsFacilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factorShernan G. Holtan, Andrea Hoeschen, Qing Cao, Mukta Arora, Veronika Bachanova
Blood Advances. 2020-04-14 - 15 citationsSteroid-dependent acute GVHD after allogeneic hematopoietic cell transplantation: risk factors and clinical outcomes.Najla El Jurdi, Ahmad Rayes, Margaret L. MacMillan, Shernan G. Holtan, Todd E. DeFor
Blood Advances. 2021-03-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
